CSPC Pharmaceutical Group's total assets for Q2 2025 were HK$46.00B, an increase of 3.63% from the previous quarter. CHJTF total liabilities were HK$11.14B for the fiscal quarter, a 5.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.